Related Experiment Videos

Platelet monoamine oxidase in families of chronic schizophrenics

Schizophrenia Bulletin
|January 1, 1980
PubMed

Insights

Low platelet monoamine oxidase (MAO) activity is observed in chronic schizophrenia. This study suggests low MAO activity in relatives indicates a potential genetic marker for schizophrenia vulnerability.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Chronic schizophrenia is frequently associated with reduced platelet monoamine oxidase (MAO) activity.
  • The genetic basis for this reduced MAO activity remains unclear.

Purpose of the Study:

  • To investigate if low platelet monoamine oxidase (MAO) activity in chronic schizophrenia patients is genetically determined.
  • To assess platelet MAO activity in first-degree relatives of individuals with chronic schizophrenia and low MAO activity.

Main Methods:

  • Platelet monoamine oxidase (MAO) activity was measured in 12 individuals with chronic schizophrenia and low MAO activity.
  • Platelet MAO activity was also assessed in 29 of their first-degree relatives.
  • Enzyme kinetic parameters (Vmax and Km) were compared between the relatives and a control group.

Main Results:

  • First-degree relatives of chronic schizophrenics exhibited significantly lower mean Vmax and Km values compared to a control group.
  • This finding suggests a familial aggregation of reduced platelet MAO activity.

Conclusions:

  • Low platelet monoamine oxidase (MAO) activity may serve as a genetic marker for vulnerability to chronic schizophrenia.
  • Further research is warranted to explore the genetic underpinnings of MAO activity in schizophrenia.

Related Concept Videos